Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases.

Abstract excerpt

Serine protease inhibitor Kazal type 1 (SPINK1) was originally identified as a trypsin inhibitor by Kazal et al. in 1948. SPINK1 is strongly elevated in pancreatitis and the elevation correlates with the severity of disease. In 2000, mutations in the SPINK1 gene were shown to be associated with chronic pancreatitis. Since then, there have been many reports on association between mutations in the SPINK1 genes and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autophagy
• Share to Carrier Proteins
• Share to Epidermal Growth Factor